Estimation of Total Burden of Head And Neck Cancer in Brazil – An Economic and Clinical Approach

Autor: RL Guerra, AL Matsuo, Flavia Mori Sarti, SD Stefani, AP Fay, Marisa Santos, Bruno Salgado Riveros, Marcelo Eidi Nita, Lucas Miyake Okumura, M.P. Rosim, G.O. Pedro, MH Massaoka, Rosa Camila Lucchetta

Publikováno v: Value in Health. 21:S26

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::33cd6d15713f9b202cf888606702c6ef
https://doi.org/10.1016/j.jval.2018.04.160

The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population.

Autor: Souza VC; Oncologia D' Or Salvador, Salvador, Brazil. Electronic address: vcscarrera@gmail.com., Monteiro FSM; Hospital Universitário de Brasília (UNB), Brasília, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Maluf FC; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Fabrício VC; Janssen Latin America, Buenos Aires, Argentina., Gidekel R; Janssen Latin America, Buenos Aires, Argentina., Gandur-Quiroga MN; Instituto de Oncologia Ángel H. Roffo, Buenos Aires, Argentina., Freitas MRP; Centro de Pesquisas Oncológicas (CEPON), Florianópolis, Brazil., Luz M; 5Hospital Erasto Gaertner, Curitiba, Brazil., Campos-Gomez S; Centro Oncológico Estatal ISSEMYM, Toluca de Lerdo, Mexico., Junior JAR; A.C. Camargo, São Paulo, Brazil., Bastos DA; Hospital Sírio-Libanês, São Paulo, Brazil., Sade JP; Instituto Alexander Fleming, Buenos Aires, Argentina., da Trindade KM; IEP Oncocentro, Fortaleza, Brazil., Mota ACA; Clínica AMO - Assistência Multidisciplinar em Oncologia, Salvador, Brazil., Fernandes RC; Santa Casa de São Paulo, São Paulo, Brazil., Ruíz AOB; Clínicas Médicas Especializadas NUCARE, Ciudad de Guatemala, Guatemala., Pereira E Silva BD; Hospital São Rafael, São Paulo, Brazil., de Oliveira FNG; CLION, Salvador, Brazil., Cutuli HJ; Asociacion de Beneficencia Hospital Sirio-Libanes, Buenos Aires, Argentina., Nogueira L; Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil., Aceituno LFG; Clinica Oncologica, Ciudad de Guatemala, Guatemala., Fernandez M; COIR - Fundación Centro Oncológico de Integración Regional, Mendoza, Argentina., Inman E; ONCOR, Saltillo Coahuila, Mexico., Caitano M; Centro de Oncologia do Paraná, Curitiba, Brazil., Herchenhorn D; Oncologia D'OR/Instituto D'OR de Ensino e Pesquisa, Rio De Janeiro, Brazil., Ardila-Salcedo J; Janssen Latin America, Bogota, Colombia., Pacheco P; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., de Jesus RG; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Gössling G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Soares A; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Centro Paulista de Oncologia (CPO) - Grupo Oncoclinicas, São Paulo, Brazil; Hospital Israelita Albert Einstein, São Paulo, Brazil., Fay AP; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Centro de Pesquisa em Oncologia (CPO) - Hospital São Lucas da PUCRS, Porto Alegre, Brazil.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102174. Date of Electronic Publication: 2024 Jul 25.

The impact of a breast cancer diagnosis on marital outcomes and factors associated with divorce and separation.

Autor: Werutsky G; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Lopes M; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., de Jesus RG; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Gazola AA; Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Pellegrini RA; Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Rebelatto TF; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Freitas LVW; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Heck AP; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., da Silva AF; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Rodrigues MF; Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Gössling G; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Giacomazzi J; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Rocha MS; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Rosa DD; Grupo Brasileiro de Estudos em Câncer de Mama Porto AlegreRS Brazil Grupo Brasileiro de Estudos em Câncer de Mama, Porto Alegre, RS, Brazil., Barrios CH; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Cronemberger EH; Centro Regional Integrado de Oncologia FortalezaCE Brazil Centro Regional Integrado de Oncologia, Fortaleza, CE, Brazil., Queiroz GS; Associação de Combate ao Câncer em Goiás Hospital Araújo Jorge GoiâniaGO Brazil Associação de Combate ao Câncer em Goiás, Hospital Araújo Jorge, Goiânia, GO, Brazil., Bines J; Instituto Nacional do Câncer Rio de JaneiroRJ Brazil Instituto Nacional do Câncer, Rio de Janeiro, RJ, Brazil., Simon SD; Grupo Oncoclínicas São PauloSP Brazil Grupo Oncoclínicas, São Paulo, SP, Brazil., Fay AP; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil.; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.

Publikováno v: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia [Rev Bras Ginecol Obstet] 2024 Jun 27; Vol. 46. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).

Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.

Autor: Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, 90127, Palermo, Italy. lorena.incorvaia@unipa.it., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, RS, Brazil. fsabinocba@gmail.com.; Oncology and Hematology Department, Hospital Sírio-Libanês, Brasilia, DF, Brazil. fsabinocba@gmail.com., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea., Roviello G; Department of Health Sciences, University of Florence, Florence, Italy., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Alej Svobody 80, Pilsen, 304 60, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, Pilsen, Czech Republic., Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536-0293, USA., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Molina-Cerrillo J; Department of Medical Oncology, University Hospital Ramón y Cajal, Madrid, Spain., Santini D; Department of Medical-Surgical Sciences and Biotechnology, La Sapienza University, Polo Pontino, Rome, Italy., Buttner T; Department of Urology, University Hospital Bonn (UKB), 53127, Bonn, Germany., Poprach A; Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czechia., Zeppellini A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Pichler M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, 8036, Graz, Austria., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Facchini G; Oncology Unit, 'S. Maria Delle Grazie' Hospital, ASL NA2 NORD, 80078, Pozzuoli, Naples, Italy., Fay AP; PUCRS School of Medicine, Porto Alegre, RS, Brazil., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology and Hematology Center of Hospital Albert Einstein, Hospital Albert Einstein, Sao Paulo, Brazil., Manneh R; Clinical Oncology, Sociedad de Oncología Y Hematología del Cesar, Valledupar, Colombia., Iezzi L; Oncology Division, Hospital 'Maria SS. Dello Splendore' ASL 4, Giulianova, Italy., Kuronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary., Russo A; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, 90127, Palermo, Italy., Bourlon MT; Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Kanesvaran R; National Cancer Centre Singapore, Singapore, Republic of Singapore., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Buti S; Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126, Parma, Italy.; Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jun 04; Vol. 73 (8), pp. 142. Date of Electronic Publication: 2024 Jun 04.

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Autor: Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. francesco.massari@aosp.bo.it., Santoni M; Oncology Unit, Macerata Hospital, via Santa Lucia 2, 62100, Macerata, Italy., Takeshita H; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Okada Y; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Tapia JC; Department of Medical Oncology, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy., Maruzzo M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy., Scagliarini S; UOC di Oncologia, Azienda Ospedaliera di Rilievo Nazionale Cardarelli di Napoli, Naples, Italy., Büttner T; Department of Urology, University Hospital Bonn (UKB), 53127, Bonn, Germany., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536-0293, USA., Galli L; Oncology Unit 2, University Hospital of Pisa, 56126, Pisa, Italy., Souza VC; Hospital São Rafael Oncologia D'Or, Salvador, BA, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil., Pichler R; Department of Urology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gandur N; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Angel Roffo, Buenos Aires, CABA, Argentina., Lam ET; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Gilbert D; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Popovic L; Oncology Institute of Vojvodina, Faculty of Medicine, University Novi Sad, Novi Sad, Serbia., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Mammone G; Department of Radiological, Oncological and Anatomo-Pathological Science, 'Sapienza' University of Rome, Viale Regina Elena 324, 00185, Rome, Italy., Berardi R; Department of Medical Oncology, Università Politecnica Delle Marche, AOU Ospedali Riuniti Delle Marche, Ancona, Italy., Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Kemp R; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Freitas M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Centro de Pesquisas Oncológicas - CEPON, Florianópolis, SC, Brazil., Luz M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Erasto Gaertner, Curitiba, PR, Brazil., Iacovelli R; Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Calabrò F; Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy., Tural D; Department of Medical Oncology, Bakirköy Dr. SadiKonuk Training and Research Hospital, Tevfik Saglam St. No: 11, Zuhuratbaba District, Bakirkoy, Istanbul, Turkey., Atzori F; Unità di Oncologia Medica, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy., Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary., Chiari R; UOC Oncologia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Fano, Italy., Campos S; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Centro Oncologico Estatal 'Dr José Luis Barrera Franco' del ISSEMYM, Toluca de Lerdo, Mexico., Caffo O; Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy., Fay AP; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Pontificia Universidade Católica do Rio Grande do Sul - PUCRS, Porto Alegre, RS, Brazil., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Zucali PA; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano - Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Rinck JA; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital AC Camargo, São Paulo, SP, Brazil., Zeppellini A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bastos DA; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Department of Oncology, Hospital Sírio-Libanês, São Paulo, SP, Brazil., Aurilio G; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy., Mota A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clínica AMO, Salvador, BA, Brazil., Trindade K; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncologia D'Or, Fortaleza, CE, Brazil., Ortega C; ASLCN2 Alba-Bra, Ospedale Michele E Pietro Ferrero, Verduno, CN, Italy., Sade JP; Instituto Alexander Fleming, Buenos Aires, CABA, Argentina., Rizzo M; Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Piazza G. Cesare 11, 70124, Bari, Italy., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Vau N; Urologic Oncology, Champalimaud Clinical Center, 1400-038, Lisbon, Portugal., Giannatempo P; Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Barillas A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clinicas Medicas Especializadas NUCARE, Guatemala City, Guatemala., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Sirio-Libanês, Brasília, DF, Brazil., Dauster B; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Sao Rafael, Salvador, BA, Brazil., Mennitto A; Department of Medical Oncology, 'Maggiore Della Carità' University Hospital, 28100, Novara, Italy., Nogueira L; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, MG, Brazil., de Carvalho Fernandes R; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Santa Casa de Sao Paulo, São Paulo, SP, Brazil., Seront E; Department of Medical Oncology, Centre Hospitalier de Jolimont, Haine Saint Paul, Belgium., Aceituno LG; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clinica Medica Especializada en Oncologia Medica, Guatemala City, Guatemala., Grillone F; UO Oncologia Azienda Ospedaliera Universitaria Renato Dulbecco PO Pugliese Ciaccio Catanzaro, Catanzaro, Italy., Cutuli HJ; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Sirio Libanes, Buenos Aires, CABA, Argentina., Fernandez M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Fundacion Centro Oncologico de Integracion Regional - COIR, Mendoza, Argentina., Bassanelli M; Medical Oncology 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Kopp RM; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Abahssain H; Medicine and Pharmacy Faculty, National Institute of Oncology, Medical Oncology Unit, Mohamed V University, Rabat, Morocco., Procopio G; Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Oncologia Medica, Ospedale Maggiore di Cremona, Cremona, Italy., Milella M; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Martignetti A; Dipartimento Oncologico USL Sud-Est Toscana-Area Senese, Località Campostaggia S.N.C, 53036, Poggibonsi, Italy., Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy., Caitano M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital do Câncer Porto Dias - Rede Mater Dei de Saúde, Belém, PA, Brazil., Inman E; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; ONCOR Life Medical Center, Saltillo, Mexico., Kanesvaran R; National Cancer Centre Singapore, Singapore, Singapore., Herchhorn D; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Instituto D'Or de Ensino e Pesquisa, Rio de Janeiro, RJ, Brazil., Santini D; Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, University of Rome, SapienzaRome, Italy., Bamias A; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Bisonni R; UOC Oncologia Medica, Ospedale A. Murri, Fermo, Italy., Mosca A; Oncology, Candiolo Cancer Institute, IRCCS-FPO, 10060, Turin, Italy., Morelli F; Medical Oncology Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, Campobasso, Italy., Maluf F; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Beneficencia Portuguesa de São Paulo, São Paulo, SP, Brazil., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Nunes F; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clinica de Oncologia - Clion, Salvador, BA, Brazil., Pinto A; Medical Oncology Department, La Paz University Hospital, Madrid, Spain., Zgura A; Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, Carol Davila; University of Medicine and Pharmacy, Bucharest, Romania., Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Via del Vespro 129, 90127, Palermo, Italy., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Zabalza IO; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Landmesser J; Klinik für Urologie, Ratzeburger Allee 160, 23538, Lübeck, Germany., Rizzo A; Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Marchetti A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rosellini M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Sorgentoni G; Oncology Unit, Macerata Hospital, via Santa Lucia 2, 62100, Macerata, Italy., Battelli N; Oncology Unit, Macerata Hospital, via Santa Lucia 2, 62100, Macerata, Italy., Buti S; Medical Oncology Unit, Department of Medicine and Surgery, University Hospital of Parma, University of Parma, Parma, Italy., Porta C; Chair of Oncology, Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro', Bari, Italy., Bellmunt J; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Apr 18; Vol. 73 (6), pp. 106. Date of Electronic Publication: 2024 Apr 18.